Brief Pain Inventory (BPI)
The BPI (Brief Pain Inventory) is a validated 9-item self-report questionnaire that measures pain severity (worst, least, average and current pain over the last 24 hours) and pain interference with daily functioning, each scored 0–10. A score ≥4 on either subscale is commonly used to define clinically significant pain. Cleeland & Ryan (1994), MD Anderson Cancer Center.
BPI Worst-Pain Severity Grade
Worst-pain rating 5–6: moderate pain.
Grades the single worst-pain item (0 = no pain, 10 = pain as bad as you can imagine), not the 4-item Pain Severity composite. Interference cutpoints (Shi et al., 2017) are shown in the scoring section.
| Worst pain in the last 24 hours (0–10) | Interpretation |
|---|---|
| 7+ | SevereWorst-pain rating 7–10: severe pain by its interference with function. |
| 5–6 | ModerateWorst-pain rating 5–6: moderate pain. |
| 1–4 | MildWorst-pain rating 1–4: mild pain. |
| 0 | No painWorst-pain rating of 0. Cutpoints were derived in cancer pain and may differ in other conditions. |
Serlin RC et al. Pain. 1995;61(2):277-284 (PMID 7659438): in cancer patients, worst-pain ratings of 1–4 correspond to mild, 5–6 to moderate and 7–10 to severe pain, based on interference with function. Educational reference only — not a diagnostic tool.
For reference only — not an assessment, diagnosis, or medical advice. This page provides scoring reference material; interpretation and clinical decisions rest with a qualified clinician.
What the BPI measures
The Brief Pain Inventory (BPI) is a validated self-report questionnaire developed by Cleeland and Ryan (1994) at the MD Anderson Cancer Center to assess the severity of pain and its impact on daily functioning. Originally developed for cancer pain research, it has since been validated across a wide range of conditions including chronic musculoskeletal pain, neuropathic pain, post-surgical pain, low back pain, and HIV-related pain. The BPI Short Form (BPI-SF) contains 9 items and takes approximately 5 minutes to complete.
The BPI has two distinct composite subscales measured on 0–10 numerical rating scales (NRS):
- Pain Severity composite — the mean of 4 items rating worst pain, least pain, average pain, and current pain ("pain right now"). Provides an overall severity score from 0 to 10.
- Pain Interference composite — the mean of 7 items rating pain interference with general activity, mood, walking ability, normal work, relations with others, sleep, and enjoyment of life. Provides an overall functional impact score from 0 to 10.
Scores of ≥4 on either subscale are commonly used to define clinically significant pain in clinical trials and practice guidelines. The BPI is copyrighted by Charles S. Cleeland, PhD; use requires permission requested through the Department of Symptom Research at MD Anderson Cancer Center, and fees may apply.
How to administer the BPI
The BPI is a patient self-report questionnaire. The Short Form (BPI-SF) contains 9 items and takes approximately 5 minutes to complete. It can also be administered verbally or by a trained interviewer when needed. Severity items refer to the last 24 hours ("pain right now" for current pain), and interference items to the past 24 hours (or past week in some research versions).
- Pain Severity composite: mean of worst, least, average, current pain (0–10)
- Pain Interference composite: mean of 7 interference items (0–10)
BPI-SF copyright Charles S. Cleeland, PhD. Use requires permission via the Department of Symptom Research, MD Anderson Cancer Center; fees may apply. This interpreter does not replace clinical assessment.
BPI scoring and interpretation
Cleeland & Ryan (1994). Severity ≥4 and/or interference ≥4 commonly defines clinically significant pain in trials and clinical guidelines. Validated in cancer, chronic, musculoskeletal, and neuropathic pain populations.
Pain Severity Scale
The Pain Severity subscale consists of 4 items, each rated 0–10 on a numerical rating scale (NRS), where 0 = "no pain" and 10 = "pain as bad as you can imagine." The composite score is the arithmetic mean of the four responses.
| Item | Prompt |
|---|---|
| Worst pain | Worst pain in the last 24 hours |
| Least pain | Least pain in the last 24 hours |
| Average pain | Average pain in the last 24 hours |
| Current pain | Pain right now |
Serlin et al. (1995) derived grading thresholds based on worst-pain ratings in cancer patients, validated by examining how each level differentially impairs functional activity, mood, and sleep. These cutpoints apply specifically to the worst-pain item rather than to the 4-item composite mean.
| Severity category | Worst-pain rating (0–10) |
|---|---|
| None | 0 |
| Mild | 1–4 |
| Moderate | 5–6 |
| Severe | 7–10 |
Pain Interference Scale
The Pain Interference subscale consists of 7 items, each rated 0–10 (0 = "does not interfere," 10 = "completely interferes"). The composite score is the mean of all 7 responses.
Shi et al. (2017) derived empirical cutpoints for total pain interference (BPI-PITS, the mean of all 7 items) in cancer patients by pooling data from three Phase III clinical trials. Cutpoints were validated against ECOG performance status (p < 0.0001).
| Interference category | BPI-PITS composite score |
|---|---|
| Mild | < 2 |
| Moderate | 2–5 |
| Severe | > 5 |
Note: these interference cutpoints were derived in cancer populations. Their applicability to non-cancer chronic pain populations has not been as formally established; Tan et al. (2004) validated the two-factor structure in chronic non-malignant pain (α = 0.88 for interference items) but did not derive specific interference-level cutpoints for that population.
BPI Interference Items
The BPI-SF asks patients to rate how much pain has interfered with each of the following domains over the past 24 hours (or past week in some research versions), from 0 ("does not interfere") to 10 ("completely interferes"):
| # | Domain | Description |
|---|---|---|
| 1 | General activity | Day-to-day physical activity and movement |
| 2 | Mood | Emotional state and psychological wellbeing |
| 3 | Walking ability | Capacity to walk and get around |
| 4 | Normal work | Work inside and outside the home |
| 5 | Relations with other people | Social functioning and interpersonal relationships |
| 6 | Sleep | Ability to fall asleep and stay asleep |
| 7 | Enjoyment of life | Pleasure, quality of life, and positive engagement |
Shi et al. (2017) further grouped these 7 items into two subscales for research purposes: activity-related interference (BPI-WAW: work, general activity, walking — optimal cutpoints 2/6) and mood-related interference (BPI-REM: relations with others, enjoyment of life, mood — optimal cutpoints 2/5).
Psychometric properties
Cleeland and Ryan (1994) report that the BPI has demonstrated reliability and validity across cultures and languages. Tan et al. (2004) confirmed the psychometric properties of the BPI in 440 patients with chronic non-malignant pain: internal consistency was acceptable (Cronbach's α = 0.85 for the severity items and 0.88 for the interference items), factor analysis yielded two distinct and independent factors, interference correlated more strongly with disability on the Roland-Morris Disability Questionnaire (r = 0.57) than severity did (r = 0.40), and both scales improved significantly with treatment. Factor analysis consistently yields two independent factors across populations, confirming that severity and interference measure related but distinct dimensions.
Limitations
- Not diagnostic. The BPI quantifies pain burden; it does not identify the cause of pain or diagnose a pain condition.
- Cancer-derived cutpoints. The severity (Serlin et al., 1995) and interference (Shi et al., 2017) cutpoints were derived in cancer populations; their applicability to chronic non-cancer pain is less formally established.
- Convention, not a validated cutoff. The ≥4 threshold for clinically significant pain is a widely used convention rather than a cutpoint from a single validation study.
- Self-report and recall. Ratings reflect the past 24 hours and can be influenced by mood, expectations and recall.
Measuring Pain in HiBoop
HiBoop does not offer the BPI; this page is reference material. For pain, HiBoop offers the PEG-3 and PMQ, with automated scoring and tracking over time.
HiBoop does not offer this scale. This page is reference material.This library is an academic and clinical reference. A scale described here is not necessarily offered in HiBoop; each page says whether it is.
Frequently Asked Questions
Is the BPI self-report or clinician-administered?
The BPI is a patient self-report questionnaire. The Short Form (BPI-SF) contains 9 items and takes approximately 5 minutes to complete. It can also be administered verbally or by a trained interviewer when needed.
What does a BPI score of ≥4 mean?
A composite score of ≥4 on either the Pain Severity or Pain Interference subscale is widely used in clinical trials and guidelines as the threshold for clinically significant pain. This convention originates from the WHO analgesic ladder context and is commonly applied in both cancer and chronic non-cancer pain populations.
What are the severity grading cutpoints for the BPI?
Based on Serlin et al. (1995), worst-pain ratings on the 0–10 numerical scale correspond to mild pain (1–4), moderate pain (5–6), and severe pain (7–10) in cancer patients. These cutpoints were validated by examining how worst-pain levels differentially impair functional activity, mood, and sleep. They are specific to the worst-pain item, not the 4-item composite mean.
Can the BPI diagnose a pain condition?
No. The BPI measures pain severity and functional interference — it is not a diagnostic tool for any specific pain condition. Diagnosis requires clinical evaluation, history, and appropriate investigations. The BPI is used to quantify pain burden, track outcomes over time, and support clinical decision-making.
Has the BPI been validated outside of cancer pain?
Yes. Tan et al. (2004) validated the BPI in 440 patients with chronic non-malignant pain, finding acceptable internal consistency (Cronbach's α = 0.85 for severity items, 0.88 for interference items) and a confirmed two-factor structure. It has since been validated in low back pain, osteoarthritis, neuropathic pain, Parkinson's disease, and multiple other conditions.
Bill this assessment
In the US, the Brief Pain Inventory (BPI) is usually billed under these CPT codes. Payer rules vary.
Measurement-based care in practice
For clinicians
HiBoop does not offer this scale. For the scales it does offer, HiBoop automates delivery, scoring and longitudinal tracking across your patient panel.
For individuals
This page is a clinical reference, not a diagnostic tool. If you have concerns about your own symptoms, bring this information to a qualified mental health professional.
References
- 1.Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994;23(2):129-138.View source
- 2.Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61(2):277-284.View source
- 3.Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain. 2004;5(2):133-137.View source
- 4.Shi Q, Mendoza TR, Dueck AC, Ma H, Zhang J, Qian Y, Bhowmik D, Cleeland CS. Determination of mild, moderate, and severe pain interference in patients with cancer. Pain. 2017;158(6):1108-1112.View source
Last reviewed: Jun 3, 2026
Related Assessments
Explore complementary clinical tools and screeners